PBS updates

Lorviqua (Lorlatinib)

lorlatinib 25 mg tablet, 90 · ORAL · PBS code 12096P

AUTHORITY_REQUIRED

What it costs

AU$6272.46 PBS-determined price per 90 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2020-08-01.
  • • Repeats: 3.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer (NSCLC)


Initial treatment


The treatment must be the sole PBS-subsidised systemic anti-cancer therapy for this PBS indication; AND

The condition must be non-squamous type non-small cell lung cancer (NSCLC) or not otherwise specified type NSCLC; AND

Patient must have a WHO performance status of 2 or less; AND

Patient must have evidence of an anaplastic lymphoma kinase (ALK) gene rearrangement in tumour material, defined as either: (i) 15% (or greater) positive cells by fluorescence in situ hybridisation (FISH) testing, (ii) positive next generation sequencing (NGS) testing; AND

Must be treated by a medical practitioner.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer (NSCLC)


Continuing treatment


The treatment must be the sole PBS-subsidised systemic anti-cancer therapy for this PBS indication; AND

Patient must have previously received PBS-subsidised treatment with this drug for this condition; AND

Patient must not develop disease progression while receiving PBS-subsidised treatment with this drug for this condition; AND

Must be treated by a medical practitioner; or

Must be treated by a nurse practitioner where both of the following are occurring: (i) patient care is being shared with a medical practitioner, (ii) the prescription continues existing therapy with this medicine.

Sponsor: Pfizer Australia Pty Ltd ABN 50 008 422 348

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.